ImClone Systems Inc (formerly IMCL)

[yaya704]

lung, why not?

Why such negativity on nsclc chances?

source: http://www.cancerpublications.com/newsle...

Some highlights of the studies to date pitting different chemo regimens vs. chemo plus erby:


LUCAS STUDY

Median OS tx arm=8.3 months chemo + erby
Median OS control arm=7 months chemo alone

One year OS tx arm=32%
One year OS control=26%

Two year OS tx arm=26%
Two year OS control=0%

NOTE: all 5 patients exhibiting grade 5 rash achieved a response.



DR KELLY’S STUDY

Median survival rate of tx arm=15.7 months
Control rate of tx arm=64.5%



DR. ROBERT’S STUDY

Control rate of tx arm=89%


Nsclc is a tough nut to crack. Other therapies like avastin and THI inhibitors which are approved have less efficacy and more toxicity. It seems to me (a layman of sorts) that lung has a fair chance to be approved.

Opinions please.

yaya